Sophia Delicou
Overview
Explore the profile of Sophia Delicou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Theocharaki K, Anastasiadi Dr A, Delicou S, Tzounakas V, Barla I, Rouvela S, et al.
Blood Adv
. 2025 Feb;
PMID: 39928952
Transfusion-dependent thalassemia (TDT) is a type of protein aggregation disease. Its clinical heterogeneity imposes challenges in effective management. Red blood cell (RBC) variables may be clinically relevant as mechanistic parts...
2.
Diamantidis M, Ikonomou G, Argyrakouli I, Pantelidou D, Delicou S
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39595957
Hemoglobinopathies, namely β-thalassemia and sickle cell disease (SCD), are hereditary diseases, characterized by molecular genetic aberrations in the beta chains of hemoglobin. These defects affect the normal production of hemoglobin...
3.
Savvidis C, Ragia D, Delicou S, Xydaki A, Rizzo M, Ilias I
Medicina (Kaunas)
. 2024 Oct;
60(10).
PMID: 39459358
: Adrenal insufficiency (AI) can be a significant concern in patients with transfusion-dependent homozygous beta thalassemia (bThal) due to the chronic disease burden and frequent blood transfusions that these patients...
4.
Delicou S, Manganas K, Xydaki A, Evliati L, Myrilla I, Rubatis L, et al.
Ther Adv Vaccines Immunother
. 2024 Sep;
12:25151355241278869.
PMID: 39314901
Background: Hemoglobinopathies, such as sickle cell disease and thalassemia, are genetic disorders that affect hemoglobin structure or production, leading to various health complications, including an increased risk of infections. Vaccinations...
5.
Kattamis A, Voskaridou E, Delicou S, Klironomos E, Lafiatis I, Petropoulou F, et al.
EJHaem
. 2023 Aug;
4(3):569-581.
PMID: 37601860
Patients with transfusion-dependent beta (β)-thalassaemia experience a broad range of complications. ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study, aimed to assess the prevalence and severity of treatment and disease complications,...
6.
Patsourakos D, Aggeli C, Dimitroglou Y, Delicou S, Xydaki K, Koukos M, et al.
Ann Hematol
. 2023 Aug;
103(9):3335-3356.
PMID: 37526674
Heart disease is among the primary causes of morbidity and mortality in β-thalassemia major (β-TM). Conventional echocardiography has failed to identify myocardial dysfunction at an early stage among these patients,...
7.
Manganas K, Delicou S, Xydaki A, Kourakli A, Evliati L, Vlachaki E, et al.
Br J Haematol
. 2023 Jul;
202(6):1192-1198.
PMID: 37438880
Sickle cell disease (SCD) is one of the most common monogenic disorders worldwide and liver complications are common in this group of patients. Our study aims to highlight the prevalence...
8.
Diamantidis M, Karanikola R, Polyzoudi C, Delicou S, Manafas A, Savera H, et al.
J Mol Med (Berl)
. 2023 Jul;
101(9):1073-1082.
PMID: 37420139
Hemoglobinopathies affect patients in the wider Mediterranean area consisting of 4 distinct subgroups: beta thalassemia major (TM), beta thalassemia intermedia (TI), sickle cell disease (SCD) and hemoglobin H disease (alpha...
9.
Manganas K, Delicou S, Xydaki A, Koskinas J
Hemoglobin
. 2022 Sep;
46(2):114-117.
PMID: 36069257
Red blood cell (RBC) transfusions have been established as one of the primary therapies in treating sickle cell anemia. However, they are not free of side effects, with overloading the...
10.
Patsourakos D, Aggeli C, Gatzoulis K, Delicou S, Dimitroglou Y, Xydaki K, et al.
Ann Hematol
. 2022 Apr;
101(7):1473-1483.
PMID: 35460387
The presence of atrial cardiomyopathy in β-thalassemia major (β-TM) patients complicates their clinical condition. The diagnosis is challenging even with cardiac magnetic resonance (CMR) imaging. Novel echocardiographic techniques are applied...